|
INTRAUTERINE GROWTH RESTRICTION |
Cochrane Database Syst Rev. 2000;(2):CD000034.
Bed rest in hospital for suspected impaired fetal growth.
G?mezoglu AM, Hofmeyr GJ.
Special Department of Research, Development and Research Training in Human
Reproduction, UNDP/UNFPA/WHO/World Bank, World Health Organisation, Geneva
27, Switzerland, CH-1211. gulmezoglum@who.ch
Background:
Bed rest in hospital or at home is widely advised for many
complications of pregnancy. The increased clinical supervision needs to be
balanced with the risk of thrombosis, the stress on the pregnant women, as
well as the costs to families and health services.
Objectives:
The objective
of this review was to assess the effects of bed rest in hospital for women
with suspected impaired fetal growth.
Search Strategy:
We searched the
Cochrane Pregnancy and Childbirth Group trials register and the Cochrane
Controlled Trials Register. Date of last search: December 1999. SELECTION
CRITERIA: Randomised trials comparing a policy of bed rest in hospital with
ambulatory management for women with suspected impaired fetal growth. DATA
COLLECTION AND ANALYSIS: Trial quality was assessed. Main Results:
One study
involving 107 women was included. Allocation of treatment was by odd or even
birth date. There were differences in baseline fetal weights and birth
weights, but these were not statistically significant (mean estimated fetal
weight deviation at enrolment was -21.7% for the bed rest group and -20.7%
for the ambulatory group; mean estimated birth weight was -19.7% for the bed
rest group and -20.6% for the ambulatory group). No differences were
detected between bed rest and ambulatory management for fetal growth
parameters (relative risk 0.43, 95% confidence interval: 0.15 to 1. 27) and
neonatal outcomes. REVIEWER'S Conclusions:
There is not enough evidence to
evaluate the use of a bed rest in hospital policy for women with suspected
impaired fetal growth.
| 
